APA (7th ed.) Citation

Alkhouri, N., Almomani, A., Le, P., Payne, J. Y., Asaad, I., Polanco, P., . . . Noureddin, M. (2024, July). The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and AGILE 4 scores: Analysis of the NHANES 2017–2018 cycle. BMC Gastroenterology.

Chicago Style (17th ed.) Citation

Alkhouri, Naim, Ashraf Almomani, Phuc Le, Julia Y. Payne, Imad Asaad, Prido Polanco, Phillip Leff, Prabhat Kumar, and Mazen Noureddin. "The Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)-related Advanced Fibrosis and Cirrhosis in the United States Population Utilizing AGILE 3 + and AGILE 4 Scores: Analysis of the NHANES 2017–2018 Cycle." BMC Gastroenterology Jul. 2024.

MLA (9th ed.) Citation

Alkhouri, Naim, et al. "The Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)-related Advanced Fibrosis and Cirrhosis in the United States Population Utilizing AGILE 3 + and AGILE 4 Scores: Analysis of the NHANES 2017–2018 Cycle." BMC Gastroenterology, Jul. 2024.